{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:07:34Z","timestamp":1795172854127,"version":"4.10.3"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41591-018-0340-z","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T12:03:58Z","timestamp":1548677038000},"page":"212-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":203,"title":["Current and future influenza vaccines"],"prefix":"10.1038","volume":"25","author":[{"given":"Seiya","family":"Yamayoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"340_CR1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","volume":"459","author":"G Neumann","year":"2009","unstructured":"Neumann, G., Noda, T. & Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931\u2013939 (2009).","journal-title":"Nature"},{"key":"340_CR2","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci USA 96, 9345\u20139350 (1999).","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"340_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","volume":"16","author":"T Watanabe","year":"2014","unstructured":"Watanabe, T. et al. Influenza virus\u2013host interactome screen as a platform for antiviral drug development. Cell Host Microbe 16, 795\u2013805 (2014).","journal-title":"Cell Host Microbe"},{"key":"340_CR4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.chom.2015.11.002","volume":"18","author":"S Tripathi","year":"2015","unstructured":"Tripathi, S. et al. Meta- and orthogonal integration of influenza \u201cOMICs\u201d data defines a role for UBR4 in virus budding. Cell Host Microbe 18, 723\u2013735 (2015).","journal-title":"Cell Host Microbe"},{"key":"340_CR5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1099\/vir.0.062836-0","volume":"95","author":"AV Cauldwell","year":"2014","unstructured":"Cauldwell, A. V., Long, J. S., Moncorge, O. & Barclay, W. S. Viral determinants of influenza A virus host range. J. Gen. Virol. 95, 1193\u20131210 (2014).","journal-title":"J. Gen. Virol."},{"key":"340_CR6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3201\/eid2404.171509","volume":"24","author":"S Yamayoshi","year":"2018","unstructured":"Yamayoshi, S. et al. Enhanced replication of highly pathogenic influenza A(H7N9) virus in humans. Emerg. Infect. Dis. 24, 746\u2013750 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"340_CR7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.chom.2017.09.008","volume":"22","author":"M Imai","year":"2017","unstructured":"Imai, M. et al. A highly pathogenic avian H7N9 influenza virus isolated from a human is lethal in some ferrets infected via respiratory droplets. Cell Host Microbe 22, 615\u2013626 e618 (2017).","journal-title":"Cell Host Microbe"},{"key":"340_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14536-0","volume":"7","author":"Y Sakai-Tagawa","year":"2017","unstructured":"Sakai-Tagawa, Y. et al. Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan. Sci. Rep. 7, 14483 (2017).","journal-title":"Sci. Rep."},{"key":"340_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Y Furuta","year":"2013","unstructured":"Furuta, Y. et al. Favipiravir (T\u2013705), a novel viral RNA polymerase inhibitor. Antiviral Res. 100, 446\u2013454 (2013).","journal-title":"Antiviral Res."},{"key":"340_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27890-4","volume":"8","author":"S Omoto","year":"2018","unstructured":"Omoto, S. et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci. Rep. 8, 9633 (2018).","journal-title":"Sci. Rep."},{"key":"340_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/095632029901000401","volume":"10","author":"CU Kim","year":"1999","unstructured":"Kim, C. U., Chen, X. & Mendel, D. B. Neuraminidase inhibitors as anti-influenza virus agents. Antivir. Chem. Chemother. 10, 141\u2013154 (1999).","journal-title":"Antivir. Chem. Chemother."},{"key":"340_CR12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/21645515.2017.1415684","volume":"14","author":"JS Tregoning","year":"2018","unstructured":"Tregoning, J. S., Russell, R. F. & Kinnear, E. Adjuvanted influenza vaccines. Hum. Vaccin. Immunother. 14, 550\u2013564 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"key":"340_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1432-1033.1979.tb13048.x","volume":"96","author":"GW Both","year":"1979","unstructured":"Both, G. W. & Air, G. M. Nucleotide sequence coding for the N-terminal region of the matrix protein influenza virus. Eur. J. Biochem. 96, 363\u2013372 (1979).","journal-title":"Eur. J. Biochem."},{"key":"340_CR14","doi-asserted-by":"crossref","first-page":"W547","DOI":"10.1093\/nar\/gkv417","volume":"43","author":"N Nolte","year":"2015","unstructured":"Nolte, N., Kurzawa, N., Eils, R. & Herrmann, C. MapMyFlu: visualizing spatio-temporal relationships between related influenza sequences. Nucleic Acids Res. 43, W547\u2013551 (2015).","journal-title":"Nucleic Acids Res."},{"key":"340_CR15","doi-asserted-by":"publisher","unstructured":"Hadfield, J., et al. Nextstrain: real-time tracking of pathogen evolution. Preprint at https:\/\/doi.org\/10.1101\/224048 (2017).","DOI":"10.1101\/224048"},{"key":"340_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature13087","volume":"507","author":"M Luksza","year":"2014","unstructured":"Luksza, M. & Lassig, M. A predictive fitness model for influenza. Nature 507, 57\u201361 (2014).","journal-title":"Nature"},{"key":"340_CR17","doi-asserted-by":"crossref","first-page":"e03883","DOI":"10.7554\/eLife.03883","volume":"3","author":"CA Russell","year":"2014","unstructured":"Russell, C. A. et al. Improving pandemic influenza risk assessment. eLife 3, e03883 (2014).","journal-title":"eLife"},{"key":"340_CR18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"340_CR19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","volume":"460","author":"Y Itoh","year":"2009","unstructured":"Itoh, Y. et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021\u20131025 (2009).","journal-title":"Nature"},{"key":"340_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","volume":"35","author":"CW Potter","year":"1979","unstructured":"Potter, C. W. & Oxford, J. S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35, 69\u201375 (1979).","journal-title":"Br. Med. Bull."},{"key":"340_CR21","first-page":"767","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond). 70, 767\u2013777 (1972).","journal-title":"J. Hyg. (Lond)."},{"key":"340_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","volume":"208","author":"J Wrammert","year":"2011","unstructured":"Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181\u2013193 (2011).","journal-title":"J. Exp. Med."},{"key":"340_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","volume":"290","author":"W Gerhard","year":"1981","unstructured":"Gerhard, W., Yewdell, J., Frankel, M. E. & Webster, R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290, 713\u2013717 (1981).","journal-title":"Nature"},{"key":"340_CR24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.80.3.840","volume":"80","author":"MZ Atassi","year":"1983","unstructured":"Atassi, M. Z. & Webster, R. G. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin. Proc. Natl Acad. Sci. USA 80, 840\u2013844 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0042-6822(80)90372-4","volume":"104","author":"RG Webster","year":"1980","unstructured":"Webster, R. G. & Laver, W. G. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104, 139\u2013148 (1980).","journal-title":"Virology"},{"key":"340_CR26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","volume":"289","author":"DC Wiley","year":"1981","unstructured":"Wiley, D. C., Wilson, I. A. & Skehel, J. J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373\u2013378 (1981).","journal-title":"Nature"},{"key":"340_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","volume":"31","author":"AJ Caton","year":"1982","unstructured":"Caton, A. J., Brownlee, G. G., Yewdell, J. W. & Gerhard, W. The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype). Cell 31, 417\u2013427 (1982).","journal-title":"Cell"},{"key":"340_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","volume":"328","author":"R Xu","year":"2010","unstructured":"Xu, R. et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357\u2013360 (2010).","journal-title":"Science"},{"key":"340_CR29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"},{"key":"340_CR30","doi-asserted-by":"crossref","first-page":"e01914","DOI":"10.7554\/eLife.01914","volume":"3","author":"T Bedford","year":"2014","unstructured":"Bedford, T. et al. Integrating influenza antigenic dynamics with molecular evolution. eLife 3, e01914 (2014).","journal-title":"eLife"},{"key":"340_CR31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","volume":"342","author":"BF Koel","year":"2013","unstructured":"Koel, B. F. et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976\u2013979 (2013).","journal-title":"Science"},{"key":"340_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0042-6822(85)90157-6","volume":"145","author":"GM Air","year":"1985","unstructured":"Air, G. M., Els, M. C., Brown, L. E., Laver, W. G. & Webster, R. G. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. Virology 145, 237\u2013248 (1985).","journal-title":"Virology"},{"key":"340_CR33","doi-asserted-by":"crossref","first-page":"12274","DOI":"10.1128\/JVI.76.23.12274-12280.2002","volume":"76","author":"U Gulati","year":"2002","unstructured":"Gulati, U. et al. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A\/Memphis\/31\/98). J. Virol. 76, 12274\u201312280 (2002).","journal-title":"J. Virol."},{"key":"340_CR34","first-page":"177","volume":"114","author":"PM Colman","year":"1985","unstructured":"Colman, P. M. & Ward, C. W. Structure and diversity of influenza virus neuraminidase. Curr. Top. Microbiol. Immunol. 114, 177\u2013255 (1985).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"340_CR35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/prot.340060402","volume":"6","author":"GM Air","year":"1989","unstructured":"Air, G. M. & Laver, W. G. The neuraminidase of influenza virus. Proteins 6, 341\u2013356 (1989).","journal-title":"Proteins"},{"key":"340_CR36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","volume":"9","author":"DS Rajao","year":"2018","unstructured":"Rajao, D. S. & Perez, D. R. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture. Front. Microbiol. 9, 123 (2018).","journal-title":"Front. Microbiol."},{"key":"340_CR37","volume":"5","author":"H Xie","year":"2015","unstructured":"Xie, H. et al. H3N2 mismatch of 2014\u201315 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps. Sci. Rep. 5, 15279 (2015).","journal-title":"Sci. Rep."},{"key":"340_CR38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/jix632","volume":"217","author":"B Young","year":"2018","unstructured":"Young, B., Sadarangani, S., Jiang, L., Wilder-Smith, A. & Chen, M. I. Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies. J. Infect. Dis. 217, 731\u2013741 (2018).","journal-title":"J. Infect. Dis."},{"key":"340_CR39","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","volume":"114","author":"SJ Zost","year":"2017","unstructured":"Zost, S. J. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 114, 12578\u201312583 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR40","doi-asserted-by":"crossref","first-page":"e1006682","DOI":"10.1371\/journal.ppat.1006682","volume":"13","author":"NC Wu","year":"2017","unstructured":"Wu, N. C. et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. 13, e1006682 (2017).","journal-title":"PLoS Pathog."},{"key":"340_CR41","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/nm.4223","volume":"22","author":"DD Raymond","year":"2016","unstructured":"Raymond, D. D. et al. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain. Nat. Med. 22, 1465\u20131469 (2016).","journal-title":"Nat. Med."},{"key":"340_CR42","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00253-010-2973-9","volume":"89","author":"SZ Feng","year":"2011","unstructured":"Feng, S. Z., Jiao, P. R., Qi, W. B., Fan, H. Y. & Liao, M. Development and strategies of cell-culture technology for influenza vaccine. Appl. Microbiol. Biotechnol. 89, 893\u2013902 (2011).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"340_CR43","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/21645515.2015.1016666","volume":"11","author":"NR Hegde","year":"2015","unstructured":"Hegde, N. R. Cell culture-based influenza vaccines: a necessary and indispensable investment for the future. Hum. Vaccin. Immunother. 11, 1223\u20131234 (2015).","journal-title":"Hum. Vaccin. Immunother."},{"key":"340_CR44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/iai.44.3.730-733.1984","volume":"44","author":"YZ Ghendon","year":"1984","unstructured":"Ghendon, Y. Z. et al. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect. Immun. 44, 730\u2013733 (1984).","journal-title":"Infect. Immun."},{"key":"340_CR45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","volume":"306","author":"H Jin","year":"2003","unstructured":"Jin, H. et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60. Virology 306, 18\u201324 (2003).","journal-title":"Virology"},{"key":"340_CR46","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1128\/JVI.79.17.11014-11021.2005","volume":"79","author":"E Hoffmann","year":"2005","unstructured":"Hoffmann, E. et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B\/Ann Arbor\/1\/66. J. Virol. 79, 11014\u201311021 (2005).","journal-title":"J. Virol."},{"key":"340_CR47","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.1503885112","volume":"112","author":"T Suzuki","year":"2015","unstructured":"Suzuki, T. et al. Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus. Proc. Natl Acad. Sci. USA 112, 7809\u20137814 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR48","doi-asserted-by":"crossref","unstructured":"Hoft, D.F. et al. Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults. Clin. Vaccine. Immunol\n                           . 24, e00414\u2013e00416 (2017).","DOI":"10.1128\/CVI.00414-16"},{"key":"340_CR49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","volume":"37","author":"MM Cox","year":"2009","unstructured":"Cox, M. M. & Hollister, J. R. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals 37, 182\u2013189 (2009).","journal-title":"Biologicals"},{"key":"340_CR50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","volume":"2","author":"MM Cox","year":"2008","unstructured":"Cox, M. M., Patriarca, P. A. & Treanor, J. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir. Viruses 2, 211\u2013219 (2008).","journal-title":"Influenza Other Respir. Viruses"},{"key":"340_CR51","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/bioinformatics\/btv381","volume":"31","author":"RA Neher","year":"2015","unstructured":"Neher, R. A. & Bedford, T. nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics 31, 3546\u20133548 (2015).","journal-title":"Bioinformatics"},{"key":"340_CR52","doi-asserted-by":"crossref","first-page":"e25953","DOI":"10.1371\/journal.pone.0025953","volume":"6","author":"K Ito","year":"2011","unstructured":"Ito, K. et al. Gnarled-trunk evolutionary model of influenza A virus hemagglutinin. PLoS One 6, e25953 (2011).","journal-title":"PLoS One"},{"key":"340_CR53","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1038\/nmicrobiol.2016.58","volume":"1","author":"C Li","year":"2016","unstructured":"Li, C. et al. Selection of antigenically advanced variants of seasonal influenza viruses. Nat. Microbiol. 1, 16058 (2016).","journal-title":"Nat. Microbiol."},{"key":"340_CR54","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1080\/21645515.2016.1215392","volume":"12","author":"IG Sakala","year":"2016","unstructured":"Sakala, I. G., Honda-Okubo, Y., Fung, J. & Petrovsky, N. Influenza immunization during pregnancy: benefits for mother and infant. Hum. Vaccin. Immunother. 12, 3065\u20133071 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"340_CR55","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjmed.2018.02.019","volume":"131","author":"W Schaffner","year":"2018","unstructured":"Schaffner, W., Chen, W. H., Hopkins, R. H. & Neuzil, K. Effective immunization of older adults against seasonal influenza. Am. J. Med. 131, 865\u2013873 (2018).","journal-title":"Am. J. Med."},{"key":"340_CR56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/21645515.2017.1367463","volume":"14","author":"C Rizzo","year":"2018","unstructured":"Rizzo, C., Rezza, G. & Ricciardi, W. Strategies in recommending influenza vaccination in Europe and US. Hum. Vaccin. Immunother. 14, 693\u2013698 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"key":"340_CR57","volume":"6","author":"J Ping","year":"2015","unstructured":"Ping, J. et al. Development of high-yield influenza A virus vaccine viruses. Nat. Commun. 6, 8148 (2015).","journal-title":"Nat. Commun."},{"key":"340_CR58","doi-asserted-by":"crossref","unstructured":"Ping, J., Lopes, T. J., Neumann, G. & Kawaoka, Y. Development of high-yield influenza B virus vaccine viruses. Proc. Natl Acad. Sci. USA 113, E8296\u2013E8305 (2016).","DOI":"10.1073\/pnas.1616530113"},{"key":"340_CR59","doi-asserted-by":"crossref","first-page":"185ra168","DOI":"10.1126\/scitranslmed.3006368","volume":"5","author":"PR Dormitzer","year":"2013","unstructured":"Dormitzer, P. R. et al. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci. Transl. Med. 5, 185ra168 (2013).","journal-title":"Sci. Transl. Med."},{"key":"340_CR60","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.vaccine.2014.11.007","volume":"33","author":"W Hu","year":"2015","unstructured":"Hu, W. et al. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages. Vaccine 33, 374\u2013381 (2015).","journal-title":"Vaccine"},{"key":"340_CR61","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5794","volume":"5","author":"PP Cheung","year":"2014","unstructured":"Cheung, P. P. et al. Generation and characterization of influenza A viruses with altered polymerase fidelity. Nat. Commun. 5, 4794 (2014).","journal-title":"Nat. Commun."},{"key":"340_CR62","doi-asserted-by":"crossref","unstructured":"Naito, T., et al. Generation of a genetically stable high-fidelity influenza vaccine strain. J. Virol. 91, e01073-16 (2017).","DOI":"10.1128\/JVI.01073-16"},{"key":"340_CR63","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2009.11.023","volume":"28","author":"J Liu","year":"2010","unstructured":"Liu, J., Mani, S., Schwartz, R., Richman, L. & Tabor, D. E. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production. Vaccine 28, 1285\u20131293 (2010).","journal-title":"Vaccine"},{"key":"340_CR64","doi-asserted-by":"crossref","first-page":"e59892","DOI":"10.1371\/journal.pone.0059892","volume":"8","author":"I Hamamoto","year":"2013","unstructured":"Hamamoto, I., Takaku, H., Tashiro, M. & Yamamoto, N. High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7. PLoS One 8, e59892 (2013).","journal-title":"PLoS One"},{"key":"340_CR65","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/JCM.43.8.4139-4146.2005","volume":"43","author":"S Hatakeyama","year":"2005","unstructured":"Hatakeyama, S. et al. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J. Clin. Microbiol. 43, 4139\u20134146 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"340_CR66","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/JVI.77.15.8418-8425.2003","volume":"77","author":"M Matrosovich","year":"2003","unstructured":"Matrosovich, M., Matrosovich, T., Carr, J., Roberts, N. A. & Klenk, H. D. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J. Virol. 77, 8418\u20138425 (2003).","journal-title":"J. Virol."},{"key":"340_CR67","doi-asserted-by":"crossref","unstructured":"Park, J. K., et al.Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A\/H1N1pdm virus. MBio 9, e02284-17 (2018).","DOI":"10.1128\/mBio.02284-17"},{"key":"340_CR68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","volume":"173","author":"YQ Chen","year":"2018","unstructured":"Chen, Y. Q. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173, 417\u2013429 e410 (2018).","journal-title":"Cell"},{"key":"340_CR69","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo, D. J., Palese, P., Wilson, P. C. & Ravetch, J. V. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605\u2013610 (2016).","journal-title":"J. Clin. Invest."},{"key":"340_CR70","doi-asserted-by":"crossref","unstructured":"Sandbulte, M. R. et al. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc. Natl Acad. Sci. USA 108, 20748\u201320753 (2011).","DOI":"10.1073\/pnas.1113801108"},{"key":"340_CR71","doi-asserted-by":"crossref","unstructured":"Rajendran, M. et al. Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by elisa and enzyme inhibition: evidence for original antigenic sin. MBio 8, e02281-16 (2017).","DOI":"10.1128\/mBio.02281-16"},{"key":"340_CR72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","volume":"100","author":"TM Doyle","year":"2013","unstructured":"Doyle, T. M. et al. Universal anti-neuraminidase antibody inhibiting all influenza A subtypes. Antiviral Res. 100, 567\u2013574 (2013).","journal-title":"Antiviral Res."},{"key":"340_CR73","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","volume":"7","author":"H Nohynek","year":"2012","unstructured":"Nohynek, H. et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7, e33536 (2012).","journal-title":"PLoS One"},{"key":"340_CR74","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","volume":"346","author":"E Miller","year":"2013","unstructured":"Miller, E. et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346, f794 (2013).","journal-title":"BMJ"},{"key":"340_CR75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2018.03.014","volume":"41","author":"B Weinberger","year":"2018","unstructured":"Weinberger, B. Adjuvant strategies to improve vaccination of the elderly population. Curr. Opin. Pharmacol. 41, 34\u201341 (2018).","journal-title":"Curr. Opin. Pharmacol."},{"key":"340_CR76","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.4049\/jimmunol.1600046","volume":"196","author":"T Onodera","year":"2016","unstructured":"Onodera, T. et al. Whole-virion influenza vaccine recalls an early burst of high-affinity memory b cell response through TLR signaling. J. Immunol. 196, 4172\u20134184 (2016).","journal-title":"J. Immunol."},{"key":"340_CR77","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1586\/14760584.2016.1164046","volume":"15","author":"CM Trombetta","year":"2016","unstructured":"Trombetta, C. M. & Montomoli, E. Influenza immunology evaluation and correlates of protection: a focus on vaccines. Expert Rev. Vaccines 15, 967\u2013976 (2016).","journal-title":"Expert Rev. Vaccines"},{"key":"340_CR78","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1256427","volume":"346","author":"JM Fonville","year":"2014","unstructured":"Fonville, J. M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996\u20131000 (2014).","journal-title":"Science"},{"key":"340_CR79","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","volume":"3","author":"M Throsby","year":"2008","unstructured":"Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3, e3942 (2008).","journal-title":"PLoS One"},{"key":"340_CR80","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"340_CR81","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"340_CR82","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","volume":"212","author":"S Bournazos","year":"2015","unstructured":"Bournazos, S., DiLillo, D. J. & Ravetch, J. V. The role of Fc-Fc\u03b3R interactions in IgG-mediated microbial neutralization. J. Exp. Med. 212, 1361\u20131369 (2015).","journal-title":"J. Exp. Med."},{"key":"340_CR83","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","volume":"15","author":"A Pincetic","year":"2014","unstructured":"Pincetic, A. et al. Type I and type II Fc receptors regulate innate and adaptive immunity. Nat. Immunol. 15, 707\u2013716 (2014).","journal-title":"Nat. Immunol."},{"key":"340_CR84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ebiom.2017.03.007","volume":"17","author":"S Yamayoshi","year":"2017","unstructured":"Yamayoshi, S. et al. A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza a virus particle release. EBioMedicine 17, 182\u2013191 (2017).","journal-title":"EBioMedicine"},{"key":"340_CR85","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. 22, 1456\u20131464 (2016).","journal-title":"Nat. Med."},{"key":"340_CR86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.immuni.2017.12.009","volume":"48","author":"KR McCarthy","year":"2018","unstructured":"McCarthy, K. R. et al. Memory B cells that cross-react with group 1 and group 2 influenza A viruses are abundant in adult human repertoires. Immunity 48, 174\u2013184 e179 (2018).","journal-title":"Immunity"},{"key":"340_CR87","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0314-z","volume":"8","author":"NB Strauli","year":"2016","unstructured":"Strauli, N. B. & Hernandez, R. D. Statistical inference of a convergent antibody repertoire response to influenza vaccine. Genome Med. 8, 60 (2016).","journal-title":"Genome Med."},{"key":"340_CR88","doi-asserted-by":"crossref","unstructured":"Laserson, U. et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc. Natl Acad. Sci. USA 111, 4928\u20134933 (2014).","DOI":"10.1073\/pnas.1323862111"},{"key":"340_CR89","first-page":"316ra192","volume":"7","author":"SF Andrews","year":"2015","unstructured":"Andrews, S. F. et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci. Transl. Med. 7, 316ra192 (2015).","journal-title":"Sci. Transl. Med."},{"key":"340_CR90","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","volume":"47","author":"CI Paules","year":"2017","unstructured":"Paules, C. I., Marston, H. D., Eisinger, R. W., Baltimore, D. & Fauci, A. S. The pathway to a universal influenza vaccine. Immunity 47, 599\u2013603 (2017).","journal-title":"Immunity"},{"key":"340_CR91","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"340_CR92","doi-asserted-by":"crossref","first-page":"e80034","DOI":"10.1371\/journal.pone.0080034","volume":"8","author":"B Brandenburg","year":"2013","unstructured":"Brandenburg, B. et al. Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS One 8, e80034 (2013).","journal-title":"PLoS One"},{"key":"340_CR93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","volume":"20","author":"DJ DiLillo","year":"2014","unstructured":"DiLillo, D. J., Tan, G. S., Palese, P. & Ravetch, J. V. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo. Nat. Med. 20, 143\u2013151 (2014).","journal-title":"Nat. Med."},{"key":"340_CR94","doi-asserted-by":"crossref","unstructured":"Steel, J. et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1, e00018-10 (2010).","DOI":"10.1128\/mBio.00018-10"},{"key":"340_CR95","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","volume":"21","author":"HM Yassine","year":"2015","unstructured":"Yassine, H. M. et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med. 21, 1065\u20131070 (2015).","journal-title":"Nat. Med."},{"key":"340_CR96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1308701110","volume":"111","author":"Y Lu","year":"2014","unstructured":"Lu, Y., Welsh, J. P. & Swartz, J. R. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines. Proc. Natl Acad. Sci. USA 111, 125\u2013130 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR97","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301\u20131306 (2015).","journal-title":"Science"},{"key":"340_CR98","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","volume":"87","author":"F Krammer","year":"2013","unstructured":"Krammer, F., Pica, N., Hai, R., Margine, I. & Palese, P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J. Virol. 87, 6542\u20136550 (2013).","journal-title":"J. Virol."},{"key":"340_CR99","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","volume":"86","author":"R Hai","year":"2012","unstructured":"Hai, R. et al. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J. Virol. 86, 5774\u20135781 (2012).","journal-title":"J. Virol."},{"key":"340_CR100","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","volume":"88","author":"R Nachbagauer","year":"2014","unstructured":"Nachbagauer, R. et al. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J. Virol. 88, 13260\u201313268 (2014).","journal-title":"J. Virol."},{"key":"340_CR101","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","volume":"107","author":"TT Wang","year":"2010","unstructured":"Wang, T. T. et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl Acad. Sci. USA 107, 18979\u201318984 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR102","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","volume":"111","author":"VV Mallajosyula","year":"2014","unstructured":"Mallajosyula, V. V. et al. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proc. Natl Acad. Sci. USA 111, E2514\u20132523 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR103","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.02608-13","volume":"88","author":"D Eggink","year":"2014","unstructured":"Eggink, D., Goff, P. H. & Palese, P. Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. J. Virol. 88, 699\u2013704 (2014).","journal-title":"J. Virol."},{"key":"340_CR104","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","volume":"186","author":"K El Bakkouri","year":"2011","unstructured":"El Bakkouri, K. et al. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J. Immunol. 186, 1022\u20131031 (2011).","journal-title":"J. Immunol."},{"key":"340_CR105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","volume":"16","author":"A Kolpe","year":"2017","unstructured":"Kolpe, A., Schepens, B., Fiers, W. & Saelens, X. M2-based influenza vaccines: recent advances and clinical potential. Expert Rev. Vaccines 16, 123\u2013136 (2017).","journal-title":"Expert Rev. Vaccines"},{"key":"340_CR106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2017.01.021","volume":"141","author":"W Tao","year":"2017","unstructured":"Tao, W. et al. Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses. Antiviral Res. 141, 62\u201372 (2017).","journal-title":"Antiviral Res."},{"key":"340_CR107","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"340_CR108","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2015.04.028","volume":"161","author":"AG Schmidt","year":"2015","unstructured":"Schmidt, A. G. et al. Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026\u20131034 (2015).","journal-title":"Cell"},{"key":"340_CR109","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","volume":"108","author":"JR Whittle","year":"2011","unstructured":"Whittle, J. R. et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl Acad. Sci. USA 108, 14216\u201314221 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nbt.3907","volume":"35","author":"EM Strauch","year":"2017","unstructured":"Strauch, E. M. et al. Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site. Nat. Biotechnol. 35, 667\u2013671 (2017).","journal-title":"Nat. Biotechnol."},{"key":"340_CR111","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.1801999115","volume":"115","author":"RU Kadam","year":"2018","unstructured":"Kadam, R. U. & Wilson, I. A. A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin. Proc. Natl Acad. Sci. USA 115, 4240\u20134245 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"340_CR112","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","volume":"126","author":"JW Yewdell","year":"1981","unstructured":"Yewdell, J. W., Frank, E. & Gerhard, W. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126, 1814\u20131819 (1981).","journal-title":"J. Immunol."},{"key":"340_CR113","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1128\/JVI.72.11.8682-8689.1998","volume":"72","author":"J Jameson","year":"1998","unstructured":"Jameson, J., Cruz, J. & Ennis, F. A. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72, 8682\u20138689 (1998).","journal-title":"J. Virol."},{"key":"340_CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","volume":"52","author":"TK Berthoud","year":"2011","unstructured":"Berthoud, T. K. et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin. Infect. Dis. 52, 1\u20137 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"340_CR115","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/eji.200737254","volume":"37","author":"GA Stoloff","year":"2007","unstructured":"Stoloff, G. A. & Caparros-Wanderley, W. Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes. Eur. J. Immunol. 37, 2441\u20132449 (2007).","journal-title":"Eur. J. Immunol."},{"key":"340_CR116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","volume":"55","author":"PJ Lillie","year":"2012","unstructured":"Lillie, P. J. et al. Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans. Clin. Infect. Dis. 55, 19\u201325 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"340_CR117","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/CVI.00098-15","volume":"22","author":"O Pleguezuelos","year":"2015","unstructured":"Pleguezuelos, O. et al. A synthetic influenza virus vaccine induces a cellular immune response that correlates with reduction in symptomatology and virus shedding in a randomized phase Ib live-virus challenge in humans. Clin. Vaccine Immunol. 22, 828\u2013835 (2015).","journal-title":"Clin. Vaccine Immunol."},{"key":"340_CR118","unstructured":"Francis, T. Proceedings of the American philosophical society. Proc. Am. Philos. Soc. 104, 572\u2013578 (1960)."},{"key":"340_CR119","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","volume":"354","author":"KM Gostic","year":"2016","unstructured":"Gostic, K. M., Ambrose, M., Worobey, M. & Lloyd-Smith, J. O. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science 354, 722\u2013726 (2016).","journal-title":"Science"},{"key":"340_CR120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3201\/eid1903.120965","volume":"19","author":"R Bodewes","year":"2013","unstructured":"Bodewes, R. et al. Recurring influenza B virus infections in seals. Emerg. Infect. Dis. 19, 511\u2013512 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"340_CR121","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JVI.02175-15","volume":"90","author":"S Yamayoshi","year":"2016","unstructured":"Yamayoshi, S., Watanabe, M., Goto, H. & Kawaoka, Y. Identification of a novel viral protein expressed from the PB2 segment of influenza A virus. J. Virol. 90, 444\u2013456 (2016).","journal-title":"J. Virol."},{"key":"340_CR122","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","volume":"22","author":"Y Wu","year":"2014","unstructured":"Wu, Y., Wu, Y., Tefsen, B., Shi, Y. & Gao, G. F. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 22, 183\u2013191 (2014).","journal-title":"Trends Microbiol."},{"key":"340_CR123","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","volume":"289","author":"IA Wilson","year":"1981","unstructured":"Wilson, I. A., Skehel, J. J. & Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution. Nature 289, 366\u2013373 (1981).","journal-title":"Nature"},{"key":"340_CR124","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","volume":"6","author":"GM Air","year":"2012","unstructured":"Air, G. M. Influenza neuraminidase. Influenza Other Respir. Viruses 6, 245\u2013256 (2012).","journal-title":"Influenza Other Respir. Viruses"},{"key":"340_CR125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","volume":"61","author":"P Palese","year":"1974","unstructured":"Palese, P., Tobita, K., Ueda, M. & Compans, R. W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397\u2013410 (1974).","journal-title":"Virology"},{"key":"340_CR126","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H. D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 78, 12665\u201312667 (2004).","journal-title":"J. Virol."},{"key":"340_CR127","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrmicro1027","volume":"2","author":"AH Reid","year":"2004","unstructured":"Reid, A. H., Taubenberger, J. K. & Fanning, T. G. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat. Rev. Microbiol. 2, 909\u2013914 (2004).","journal-title":"Nat. Rev. Microbiol."},{"key":"340_CR128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.chom.2014.05.006","volume":"15","author":"T Watanabe","year":"2014","unstructured":"Watanabe, T. et al. Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. Cell Host Microbe 15, 692\u2013705 (2014).","journal-title":"Cell Host Microbe"},{"key":"340_CR129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/infdis\/jiv534","volume":"213","author":"C Viboud","year":"2016","unstructured":"Viboud, C. et al. Global mortality impact of the 1957\u20131959 influenza pandemic. J. Infect. Dis. 213, 738\u2013745 (2016).","journal-title":"J. Infect. Dis."},{"key":"340_CR130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.1176062","volume":"324","author":"C Fraser","year":"2009","unstructured":"Fraser, C. et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324, 1557\u20131561 (2009).","journal-title":"Science"},{"key":"340_CR131","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1056\/NEJMoa0903812","volume":"360","author":"V Shinde","year":"2009","unstructured":"Shinde, V. et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N. Engl. J. Med. 360, 2616\u20132625 (2009).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0340-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:42:00Z","timestamp":1733942520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0340-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0340-z","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.K. has received speaker\u2019s honoraria from Toyama Chemical and Astellas Inc.; has received grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Otsuka Pharmaceutical Co., Ltd., and Denka Seiken Co., Ltd.; and is a co-founder of FluGen. S.Y. has no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}